3α,5α-Dihydrolevonorgestrel
A synthetic progestogen and active metabolite of levonorgestrel
3α,5α-Dihydrolevonorgestrel is a synthetic progestogen and an active metabolite of the widely used contraceptive drug levonorgestrel. It is part of the class of compounds known as 19-norprogesterone derivatives, which are characterized by the removal of the 19-methyl group from the progesterone structure.
Chemical Structure and Properties[edit | edit source]
3α,5α-Dihydrolevonorgestrel is a steroid with the chemical formula C₁₉H₂₆O₂. It is a derivative of levonorgestrel, which is a synthetic progestogen used in various hormonal contraceptives. The compound is characterized by its 3α,5α-dihydro configuration, which refers to the specific stereochemistry of the hydrogen atoms at the 3rd and 5th positions of the steroid nucleus.
Pharmacology[edit | edit source]
As an active metabolite of levonorgestrel, 3α,5α-Dihydrolevonorgestrel contributes to the overall progestogenic activity of the parent compound. It binds to the progesterone receptor with high affinity, exerting effects that include the suppression of ovulation, thickening of the cervical mucus, and alteration of the endometrium to prevent implantation of a fertilized egg.
Metabolism[edit | edit source]
Levonorgestrel undergoes extensive hepatic metabolism in the liver, where it is reduced to several metabolites, including 3α,5α-Dihydrolevonorgestrel. This reduction is catalyzed by the enzyme 5α-reductase, which is also involved in the metabolism of other steroid hormones such as testosterone.
Clinical Significance[edit | edit source]
The presence of 3α,5α-Dihydrolevonorgestrel as a metabolite is significant in understanding the pharmacokinetics and pharmacodynamics of levonorgestrel. Its activity contributes to the efficacy of levonorgestrel-containing contraceptives, which are used in various forms such as oral pills, intrauterine devices (IUDs), and emergency contraception.
Research and Development[edit | edit source]
Research into the specific roles and effects of 3α,5α-Dihydrolevonorgestrel is ongoing, with studies focusing on its receptor binding characteristics, metabolic pathways, and potential therapeutic applications beyond contraception.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
